SEB Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
SEB Asset Management's AZN Position: Q3 2026 in Review
SEB Asset Management increased its AstraZeneca (AZN) stake by 19% in Q3 2026, buying an estimated $183M and bringing the position to 6,832,972 shares worth $1.12B. The position accounts for 4.14% of the portfolio, ranked #4.
SEB Asset Management first reported a position in AZN in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.16B in Q1 2026. 1,441 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- SEB Asset Management held 6,832,972 shares of AstraZeneca worth $1.12B as of Q3 2026.
- SEB Asset Management bought 1,096,324 AstraZeneca shares in Q3 2026, an estimated $183M.
- AstraZeneca made up 4.14% of SEB Asset Management's portfolio in Q3 2026, its #4 holding.
- SEB Asset Management first reported a position in AstraZeneca in Q1 2026 and has held it in 3 quarters since.
- SEB Asset Management's AstraZeneca position peaked at $1.16B in Q1 2026.
- 1,441 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.